Literature DB >> 33446891

Simulating SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing app containment.

Alberto Ferrari1, Enrico Santus2, Davide Cirillo3,4, Miguel Ponce-de-Leon3, Nicola Marino4,5, Maria Teresa Ferretti4, Antonella Santuccione Chadha4, Nikolaos Mavridis4,6, Alfonso Valencia3,7.   

Abstract

Targeted contact-tracing through mobile phone apps has been proposed as an instrument to help contain the spread of COVID-19 and manage the lifting of nation-wide lock-downs currently in place in USA and Europe. However, there is an ongoing debate on its potential efficacy, especially in light of region-specific demographics. We built an expanded SIR model of COVID-19 epidemics that accounts for region-specific population densities, and we used it to test the impact of a contact-tracing app in a number of scenarios. Using demographic and mobility data from Italy and Spain, we used the model to simulate scenarios that vary in baseline contact rates, population densities, and fraction of app users in the population. Our results show that, in support of efficient isolation of symptomatic cases, app-mediated contact-tracing can successfully mitigate the epidemic even with a relatively small fraction of users, and even suppress altogether with a larger fraction of users. However, when regional differences in population density are taken into consideration, the epidemic can be significantly harder to contain in higher density areas, highlighting potential limitations of this intervention in specific contexts. This work corroborates previous results in favor of app-mediated contact-tracing as mitigation measure for COVID-19, and draws attention on the importance of region-specific demographic and mobility factors to achieve maximum efficacy in containment policies.

Entities:  

Year:  2021        PMID: 33446891     DOI: 10.1038/s41746-020-00374-4

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  7 in total

Review 1.  Blockchain for COVID-19: Review, Opportunities, and a Trusted Tracking System.

Authors:  Dounia Marbouh; Tayaba Abbasi; Fatema Maasmi; Ilhaam A Omar; Mazin S Debe; Khaled Salah; Raja Jayaraman; Samer Ellahham
Journal:  Arab J Sci Eng       Date:  2020-10-12       Impact factor: 2.334

2.  Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020.

Authors:  Tobias M Holden; Reese A K Richardson; Philip Arevalo; Wayne A Duffus; Manuela Runge; Elena Whitney; Leslie Wise; Ngozi O Ezike; Sarah Patrick; Sarah Cobey; Jaline Gerardin
Journal:  medRxiv       Date:  2021-04-20

3.  The ethical use of high-performance computing and artificial intelligence: fighting COVID-19 at Barcelona Supercomputing Center.

Authors:  Ulises Cortés; Atia Cortés; Dario Garcia-Gasulla; Raquel Pérez-Arnal; Sergio Álvarez-Napagao; Enric Àlvarez
Journal:  AI Ethics       Date:  2021-05-06

4.  A Case Study of Bluetooth Technology as a Supplemental Tool in Contact Tracing.

Authors:  Ryan Admiraal; Jules Millen; Ankit Patel; Tim Chambers
Journal:  J Healthc Inform Res       Date:  2022-01-19

5.  COVID-19 Flow-Maps an open geographic information system on COVID-19 and human mobility for Spain.

Authors:  Miguel Ponce-de-Leon; Javier Del Valle; José María Fernandez; Marc Bernardo; Davide Cirillo; Jon Sanchez-Valle; Matthew Smith; Salvador Capella-Gutierrez; Tania Gullón; Alfonso Valencia
Journal:  Sci Data       Date:  2021-11-30       Impact factor: 6.444

6.  Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020.

Authors:  Tobias M Holden; Reese A K Richardson; Philip Arevalo; Wayne A Duffus; Manuela Runge; Elena Whitney; Leslie Wise; Ngozi O Ezike; Sarah Patrick; Sarah Cobey; Jaline Gerardin
Journal:  BMC Public Health       Date:  2021-06-10       Impact factor: 3.295

7.  Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review.

Authors:  Kevin Jenniskens; Martin C J Bootsma; Johanna A A G Damen; Michiel S Oerbekke; Robin W M Vernooij; René Spijker; Karel G M Moons; Mirjam E E Kretzschmar; Lotty Hooft
Journal:  BMJ Open       Date:  2021-07-12       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.